## GPT-Rosalind & AI in Life Sciences: A Hacker News Summary OpenAI recently launched “GPT-Rosalind,” a new model geared towards life sciences research, sparking discussion on Hacker News. While some are impressed with the advancements in AI reasoning – with some claiming it reaches “PhD-level” expertise – others express skepticism and concern. A key point of contention is the lack of comparative performance data, specifically omitting results for Anthropic models and focusing solely on the default GPT-5.4. Users pointed to independent projects significantly boosting competitor model performance. There's debate around the ethics of profiting from the name of Rosalind Franklin, a crucial figure in discovering the structure of DNA, with some finding it exploitative. Concerns were also raised about the potential for misuse, even with safeguards, and the overestimation of AI’s current capabilities in genuinely advancing scientific discovery versus simply identifying potential drug targets. Many believe AI’s immediate value lies in assisting with tasks *around* core science – like coding for modeling or improving data analysis – rather than replacing scientists themselves. Some users challenged OpenAI to demonstrate real-world impact by tackling pressing global health issues like developing affordable vaccines for Tuberculosis or HIV.